| | Lipoxygenase Inhibitors
- 3-[[3-fluoro-5-(tetrahydro-4-methoxy-2H-pyran-4-yl)phenoxy]methyl]-1-[4-(methylsulfonyl)phenyl]-5-phenyl-1H-pyrazole
A dual COX-2/5-LO inhibitor; a potential therapeutic agent for prostate cancer and inflammatory disease.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205108 | 443919-96-8 | C29H29FN2O5S | 1 mg/5 mg |
- 5(S)-HETrE
This is produced by the action of 5-LO when mead acid is the substrate. There are no literature reports of biological activity or further metabolic fate of 5(S)-HETrE.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221073 | n.n. | C20H34O3 | 25 µg/50 µg |
- 5(S)-HpEPE
This is a monohydroperoxy polyunsaturated fatty acid produced by the action of 5-LO on EPA. It is metabolized to LTA5, a key intermediate in formation of the 5-series leukotrienes. Alternatively, 5(S)-HpEPE is reduced to 5(S)-HEPE by peroxidases.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221074 | n.n. | C20H30O4 | 25 µg/50 µg |
- 5(S),6(R)-7-trihydroxymethyl Heptanoate
A C-7 truncated analog of LXA4 that is equiactive as LXA4 in inhibition of LTB4-induced polymorphonuclear chemotaxis.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221076 | n.n. | C8H16O5 | 1 mg/5 mg |
- AA-861
Potent, selective and orally active 5-lipoxygenase inhibitor, shown to enhance and accelerate fracture healing, increase Ca2+ concentration in MDCK cells, and is used to probe fatty acid metabolism and leukotriene production.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200570 | 80809-81-0 | C21H26O3 | 20 mg/100 mg |
- Auranofin
A gold(I)-phosphine thiolate small molecule. Blocks the release of pro-inflammatory mediators from basophiles and mast cells. Inhibits mitochondrial thioredoxin reductase and 5-lipoxygenase. Quenches reactive singlet oxygen species.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-202476 | 34031-32-8 | C20H34AuO9PS | 25 mg/100 mg |
- Baicalein
A flavone that inhitbits Ca2+ uptake, certain types of lipoxygenase, leukotriene biosynthesis and the release of lysosomal enzymes. It is a potent anti-inflammatory agent.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200494 | 491-67-8 | C15H10O5 | 10 mg/50 mg |
- BW A4C
Selective 5-lipoxygenase (5-LOX) inhibitor. Inhibits synthesis of LTB4.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-210981 | 106328-57-8 | C17H17NO3 | 5 mg/25 mg |
- BW B70C
A selective arachidonic acid 5-lipoxygenase inhibitor. Reported to decrease 12-HETE formation, leukotriene C4 synthesis, and decrease the formation of oligonucleosomal and high molecular weight DNA fragments.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200633 | 134470-38-5 | C17H17FN2O3 | 5 mg/25 mg |
- Caffeic Acid
Inhibits 5-lipoxygenase (IC50=3.7 µM). At 2.2 µM, caffeic acid selectively inhibits 15-lipoxygenase. Shows moderate inhibition of human tyrosinase. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200499 | 331-39-5 | C9H8O4 | 1 g/5 g |
- CDC
A metabolite of ciproflaxacin, CDC is a selective 12-lipoxygenase inhibitor and a 15- and 5-LO inhibiter respectively in isolated enzyme preparations.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200562 | 132465-11-3 | C19H15NO4 | 10 mg/50 mg |
- Croton Oil
Natural source of phorbol and phorbol esters, obtained and purified from Croton tiglium L.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-204698 | 8001-28-3 | n.n. | 10 g/25 g |
- Esculetin
A phenolic compound that acts as a 5-LO inhibitor. Reported to display anti-inflammatory and antioxidant properties, as well as induce cell cycle arrest and apoptosis.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200486 | 305-01-1 | C9H6O4 | 1 g |
- Ethyl 3,4-dihydroxybenzylidenecyanoacetate
An inhibitor of 12- and 15-lipoxygenase. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-202603 | 132464-92-7 | C12H11NO4 | 25 mg |
- ETI
An inhibitor of lipoxygenase activity, in particle 5-lipoxygenase which affects cell proliferation. Also shown to reduce oxidative metabolism of arachidonic acid.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200762 | 13488-22-7 | C20H28O2 | 1 mg/10 mg |
- Ferulic acid
Chemopreventive caffeic acid analogue.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-204753 | 1135-24-6 | C10H10O4 | 5 g/25 g |
- Gossypol
Male antifertility agent with antispermatogenic activity and is also shown to display anitumor, anitviral, and antioxidant properties. Reversible inhibitor of phosphotase 2B and protein kinase C.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200501 | 303-45-7 | C30H30O8 | 20 mg/100 mg |
- (±)-Jasmonic Acid
A member of the jasmonates produced in the octadecanoid
pathway. This compound is a plant growth regulator involved in the signaling mechanisms for a variety of conditions.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205355 | 77026-92-7 | C12H18O3 | 100 mg/250 mg |
- L-655,238
Potent and selective inhibitor of 5-LO-activating protein (FLAP).| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221799 | n.n. | C22H25NO2 | 10 mg/50 mg |
- NDGA (Nordihydroguaiaretic acid)
NDGA (Nordihydroguaiaretic acid) is an anti-oxidant lipoxeygenase inhibitor lignan found in Larrea tridentata.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200487 | 500-38-9 | C18H22O4 | 1 g |
- MK-886 sodium salt
A potent and selective inhibitor of 5-lipoxygenase-activating protein (FLAP). Binds to FLAP with high affinity and prevents the activation of 5-lipoxygenase.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200608 | 118427-55-7 | C27H33ClNO2S•Na | 5 mg/25 mg/1 mg |
- PD-146176
A potent and selective 15-lipoxygenase inhibitor which lacks significant nonspecific antioxidant properties. Suppresses atherogenesis and limits atherosclerotic lesion development in New Zealand White rabbits.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200678 | 4079-26-9 | C15H11NS | 10 mg/50 mg |
- Zileuton
Orally active 5-lipoxygenase (5-LOX) inhibitor that inhibits LTB4 synthesis (IC50 values are 0.56, 2.3 and 2.6 μM in dog, rat and human blood respectively). Inhibits antigen-induced contraction of tracheal strips in vitro (IC50 = 6 μM) and shows antiasthmatic activity in vivo. Also weakly inhibits CYP1A2 (Ki = 66 - 98 μM).
| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-204417 | 111406-87-2 | C11H12N2O2S | 10 mg/50 mg |
|